Strategy for Aortic Surgery Hemostasis

PHASE2/PHASE3UnknownINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Ascending Aorta AbnormalityAscending Aortic DissectionAscending Aorta Aneurysm

Interventions

COMBINATION_PRODUCT

TDM-621

The TDM-621 is a topic hemostatic product which will be used during ascending aortic surgery.

Trial Locations (1)

RECRUITING

Heart Institute (InCor) University of Sao Paulo, São Paulo